Abstract:Abstract Background Due to post-cleavage residence of the Cas9-sgRNA complex at its target, Cas9-induced DNA double strand breaks (DSBs) have to be exposed in order to engage DSB repair pathways. Target interaction of Cas9-sgRNA determines its target-binding affinity and modulates its post-cleavage target-residence duration and exposure of Cas9-induced DSBs. This exposure by different mechanisms may initiate variable cellular DNA damage response, thus influencing DSB repair pathway choices and contributing to mutational heterogeneity in genome editing. However, this regulation of DSB repair pathway choices is poorly understood. Results In repair of Cas9-induced DSBs, repair pathway choices vary widely at different target sites and classical non-homologous end joining (c-NHEJ) is not even engaged at some sites. Weakening target interaction of Cas9-sgRNA promotes bias towards c-NHEJ, which is intrinsically accurate for Cas9-induced DSBs. As an important strategy for enhancing homology-directed repair, inactivation of c-NHEJ however aggravates off-target activities of Cas9-sgRNA due to its weak interaction with off-target sites. By dislodging Cas9-sgRNA from its cleaved targets, DNA replication alters DSB end configurations and suppresses c-NHEJ in favor of other repair pathways whereas transcription has little effect on DSB repair pathway choices. Dissociation of Cas9-sgRNA from its cleaved target by DNA replication may generate three-ended DSBs, resulting in palindromic fusion of sister chromatids, a potential source for CRISPR/Cas9-induced on-target chromosomal rearrangements. Conclusions Target interaction of Cas9-sgRNA modulates DSB repair pathway choices likely through varying dissociation of Cas9-sgRNA from cleaved DNA, thus widening on-target and off-target mutational spectra in CRISPR/Cas9 genome editing.

The Collateral Activity of RfxCas13d Can Induce Lethality in a RfxCas13d Knock-in Mouse Model

Collateral cleavage of 28s rRNA by RfxCas13d causes death of mice

Collateral Activity of the CRISPR/RfxCas13d System in Human Cells.

High-fidelity Cas13 variants for targeted RNA degradation with minimal collateral effects.

Low copy CRISPR-Cas13d mitigates collateral RNA cleavage

CRISPR/Cas9 Targeting Events Cause Complex Deletions and Insertions at 17 Sites in the Mouse Genome

Collateral Effects: The CRISPR‐Cas13a Gene‐Editing System Induces Collateral Cleavage of RNA in Glioma Cells (Adv. Sci. 20/2019)

The CRISPR-Cas13a Gene-Editing System Induces Collateral Cleavage of RNA in Glioma Cells.

The Bacterial Enzyme RfxCas13d Is Less Neurotoxic Than PspCas13b and Could Be a Promising RNA Editing and Interference Tool in the Nervous System

Intrinsic targeting of host RNA by Cas13 constrains its utility

Abstract 19722: Cardiac Deletion of miRNA-17-92 Cluster Augments Acute Myocardial Ischemia-Reperfusion Injury

Intrinsic RNA Targeting Constrains the Utility of CRISPR-Cas13 Systems

RNA-guided cell targeting with CRISPR/RfxCas13d collateral activity in human cells

Efficient and Reversible Cas13d-mediated Knockdown with an All-in-one Lentivirus-Vector

The Effects of Length and Sequence of Grna on Cas13b and Cas13d Activity in Vitro and in Vivo

CRISPR/Cas9-mediated Genome Editing Induces Gene Knockdown by Altering the Pre-Mrna Splicing in Mice

Optimizing a CRISPR-Cas13d Gene Circuit for Tunable Target RNA Downregulation with Minimal Collateral RNA Cutting

CRISPR/Cas13d-Mediated Microbial RNA Knockdown

A CRISPR/RfxCas13d-mediated strategy for efficient RNA knockdown in mouse embryonic development

Target Interaction of Cas9-sgRNA Influences DNA Double Strand Break Repair Pathway Choices in CRISPR/Cas9 Genome Editing

Engineered CRISPR RNA improves the RNA cleavage efficiency of hfCas13X